Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P35558: Variant p.Arg55Gln

Phosphoenolpyruvate carboxykinase, cytosolic [GTP]
Gene: PCK1
Feedback?
Variant information Variant position: help 55 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glutamine (Q) at position 55 (R55Q, p.Arg55Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 55 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 622 The length of the canonical sequence.
Location on the sequence: help AELCQPDHIHICDGSEEENG R LLGQMEEEGILRRLKKYDNC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         AELCQPDHIHICDGSEEENGRLLGQMEEEGILRRLKKYDNC

Mouse                         AQLCQPEYIHICDGSEEEYGQLLAHMQEEGVIRKLKKYDNC

Rat                           AQLCQPEYIHICDGSEEEYGRLLAHMQEEGVIRKLKKYDNC

Pig                           AKLCQPDQIHICDGSEEENQQLLSHMEEEGVIKRLKKYDNC

Bovine                        AKLCRPDQVHICDGSEEENRQLLSHMEEEGVIKRLKKYDNC

Chicken                       AKLCQPESIHICDGSEEENKKILDIMVEQGMIKKLSKYENC

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 622 Phosphoenolpyruvate carboxykinase, cytosolic [GTP]
Modified residue 70 – 70 N6-acetyllysine; by p300/EP300
Modified residue 71 – 71 N6-acetyllysine; by p300/EP300
Alternative sequence 4 – 320 Missing. In isoform 2.
Mutagenesis 70 – 70 K -> R. Abolishes acetylation and increases protein stability; when associated with R-71 and R-594.
Mutagenesis 71 – 71 K -> R. Abolishes acetylation and increases protein stability; when associated with R-70 and R-594.
Helix 50 – 62



Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS GLN-55; THR-60; ILE-138; VAL-267; LYS-276; ILE-368 AND SER-427;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.